Adaptilens Announces $17.5M in Series A Financing
We are thrilled to announce that Adaptilens has secured $17.5 million in Series A financing, led by Xontogeny and Perceptive Xontogeny Venture Fund, with participation
We are thrilled to announce that Adaptilens has secured $17.5 million in Series A financing, led by Xontogeny and Perceptive Xontogeny Venture Fund, with participation
Follow our progress on